Stay updated on Crenezumab Long-Term Safety in Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the Crenezumab Long-Term Safety in Alzheimer's Clinical Trial page.

Latest updates to the Crenezumab Long-Term Safety in Alzheimer's Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.3.1 was removed. These updates appear to be backend/versioning changes and do not modify any trial details or page content.SummaryDifference0.0%

- Check25 days agoChange DetectedRevision: v3.3.1 is now displayed on the page, replacing the previous Revision: v3.2.0. Other page content, including the study details and layout, appears unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check32 days agoChange DetectedRemoved the government funding status notice about operating status and delays. Study details and data remain unchanged, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check46 days agoChange DetectedNo significant additions or deletions were detected; the Study Details page content and layout appear unchanged between the screenshots.SummaryDifference0.2%

- Check76 days agoChange DetectedUpgrade noted: from v3.0.2 to v3.2.0, implying a newer release version is now referenced.SummaryDifference0.1%

- Check77 days agoChange DetectedVersion bumped from v3.0.2 to v3.1.0; no other substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to Crenezumab Long-Term Safety in Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Crenezumab Long-Term Safety in Alzheimer's Clinical Trial page.